Online first
Original Article
Published online: 2024-08-19

open access

Page views 316
Article views/downloads 136
Get Citation

Connect on Social Media

Connect on Social Media

Zero-fluoroscopy catheter ablation of premature ventricular contractions: comparative outcomes from the right ventricular outflow tract and other ventricular sites

Dariusz Rodkiewicz1, Karol Momot12, Edward Koźluk1, Agnieszka Piątkowska13, Karolina Rogala1, Liana Puchalska2, Artur Mamcarz4
Pubmed: 39158516

Abstract

Background: The three-dimensional electroanatomic mapping (EAM) system allows performing catheter ablation (CA) without fluoroscopy in patients with premature ventricular contractions (PVCs). The right ventricle outflow tract (RVOT) location is favorable for performing zero-fluoroscopy CA. Non-RVOT zero-fluoroscopy CA is a challenging procedure. The study aimed to evaluate the efficacy and safety of zero-fluoroscopy CA using the EAM in patients with PVCs from RVOT and non-RVOT.

Methods: Completely zero-fluoroscopy CA of PVCs guided by EAM was performed in 107 patients with PVCs. 54 patients underwent zero-fluoroscopy RVOT CA. The remaining 53 patients underwent zero-fluoroscopy non-RVOT CA. Demographic and clinical baseline characteristics, procedure parameters, and follow-up were obtained from medical records. Primary outcomes were the acute and the permanent success rate (12-month follow-up), complications, and procedure time.

Results: There were no significant differences between groups regarding baseline characteristics. Acute procedural success was achieved in 52 patients (94,44%) in the RVOT zero-fluoroscopy CA group and in 45 patients (86,54%) in the non-RVOT zero-fluoroscopy CA group (ns). A long-term success rate was achieved in 50 patients (90,74%) in the RVOT zero-fluoroscopy CA group and in 44 patients (84,62%) in the non-RVOT zero-fluoroscopy CA group (ns). The median procedure time was 80.5 minutes in the RVOT group and 90 minutes in the non-RVOT group (ns). There were two complications in the non-RVOT group (ns).

Conclusions: There were no differences in procedure time efficacy and safety zero-fluoroscopy ablation between RVOT and non-RVOT locations. Non-fluoroscopy CA of PVCs is a feasible, safe, and efficient procedure.

Article available in PDF format

View PDF Download PDF file

References

  1. Rillig A, Lin T, Ouyang F, et al. Which Is The Appropriate Arrhythmia Burden To Offer RF Ablation For RVOT Tachycardias? J Atr Fibrillation. 2014; 7(4): 1157.
  2. Venneri L, Rossi F, Botto N, et al. Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights from the National Research Council's Biological Effects of Ionizing Radiation VII Report. Am Heart J. 2009; 157(1): 118–124.
  3. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012; 380(9840): 499–505.
  4. Maffei F, Angelini S, Forti GC, et al. Spectrum of chromosomal aberrations in peripheral lymphocytes of hospital workers occupationally exposed to low doses of ionizing radiation. Mutat Res. 2004; 547(1-2): 91–99.
  5. Rehani MM. Training of interventional cardiologists in radiation protection--the IAEA's initiatives. Int J Cardiol. 2007; 114(2): 256–260.
  6. Wang C, Zhang Y, Hong F, et al. Pulmonary artery: A pivotal site for catheter ablation in idiopathic RVOT ventricular arrhythmias. Pacing Clin Electrophysiol. 2017; 40(7): 803–807.
  7. Lamba J, Redfearn DP, Michael KA, et al. Radiofrequency catheter ablation for the treatment of idiopathic premature ventricular contractions originating from the right ventricular outflow tract: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2014; 37(1): 73–78.
  8. Romero J, Diaz JC, Gamero M, et al. Fluoroless Catheter Ablation of Left Ventricular Summit Arrhythmias: A Step-by-Step Approach. Card Electrophysiol Clin. 2023; 15(1): 75–83.
  9. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006; 6(9): 702–713.
  10. Health Ri, Phase I. Letter Report . Washington (DC. 1998; 1998.
  11. Radiation UNSCotEoA. Report: United Nations. ; 1988.
  12. Rodkiewicz D, Koźluk E, Piątkowska A, et al. Efficacy and Safety of Zero-Fluoroscopy Approach during Catheter Ablation of Accessory Pathway. J Clin Med. 2022; 11(7).
  13. Mainprize JG, Yaffe MJ, Chawla T, et al. Effects of ionizing radiation exposure during pregnancy. Abdom Radiol (NY). 2023; 48(5): 1564–1578.
  14. Abalo KD, Rage E, Leuraud K, et al. Early life ionizing radiation exposure and cancer risks: systematic review and meta-analysis. Pediatr Radiol. 2021; 51(1): 45–56.
  15. Rodkiewicz D, Koźluk E, Momot K, et al. Efficacy of Catheter Ablation Using the Electroanatomical System without the Use of Fluoroscopy in Patients with Ventricular Extrasystolic Beats. J Clin Med. 2023; 12(14).
  16. Di Biase L, Al-Ahamad A, Santangeli P, et al. Safety and outcomes of cryoablation for ventricular tachyarrhythmias: results from a multicenter experience. Heart Rhythm. 2011; 8(7): 968–974.
  17. Guandalini GS, Liang JJ, Marchlinski FE. Ventricular Tachycardia Ablation: Past, Present, and Future Perspectives. JACC Clin Electrophysiol. 2019; 5(12): 1363–1383.
  18. Lador A, Da-Wariboko A, Tavares L, et al. Alcohol Ablation for Ventricular Tachycardia. Methodist Debakey Cardiovasc J. 2021; 17(1): 19–23.
  19. Mohanty S, Burkhardt JD, Di Biase L, et al. Best ablation strategy in patients with premature ventricular contractions with multiple morphology: a single-centre experience. Europace. 2023; 25(5).
  20. Chung WH, Hayase J, Do DH, et al. Clinical predictors and implications of cardiac inflammation detected on positron emission tomography (PET) in patients referred for premature ventricular complex (PVC) ablation. J Interv Card Electrophysiol. 2023; 66(5): 1253–1263.
  21. Ishidoya Y, Ranjan R. Using MRI to predict ventricular tachycardia recurrence and provide guidance for ablation? Heart Rhythm. 2022; 19(10): 1611–1612.